1983
DOI: 10.1203/00006450-198302000-00002
|View full text |Cite
|
Sign up to set email alerts
|

Four-Hydroxyphenylpyruvic Acid Oxidase Deficiency with Normal Fumarylacetoacetase: a New Variant Form of Hereditary Hypertyrosinemia

Abstract: SummaryEnzymatic studies on the liver of an infant are described-a case of hypertyrosinemia without hepatic dysfunction. His parents were siblings and the mother had hypertyrosinemia. Excessive amounts of 4hydroxyphenylpyruvic acid (pHPP), 4-hydroxyphenylacetic acid (pHPL), and 4-hydroxyphenylacetic acid (pHPA) were found to be excreted in the patient's urine as well as in the urine of the mother and the inhibitor of porphobilinogen synthetase,was not found. Soluble tyrosine aminotransferase (s-TAT), separated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
34
0

Year Published

1984
1984
2006
2006

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(35 citation statements)
references
References 16 publications
(20 reference statements)
1
34
0
Order By: Relevance
“…HGA production in plants is critical for the production of plastoquinone and tocopherols, essential quinine compounds, and growth of 4HPPD mutant lines can be rescued either by expression of 4HPPD or by application of exogenous HGA (29,30). In humans, the role of 4HPPD can be more directly correlated to tyrosine degradation, since humans deficient in 4HPPD function are at risk for tyrosinemia type III, a disorder caused by the accumulation of tyrosine and phenolic metabolites that leads to mental retardation or neurological symptoms (12).…”
Section: Discussionmentioning
confidence: 99%
“…HGA production in plants is critical for the production of plastoquinone and tocopherols, essential quinine compounds, and growth of 4HPPD mutant lines can be rescued either by expression of 4HPPD or by application of exogenous HGA (29,30). In humans, the role of 4HPPD can be more directly correlated to tyrosine degradation, since humans deficient in 4HPPD function are at risk for tyrosinemia type III, a disorder caused by the accumulation of tyrosine and phenolic metabolites that leads to mental retardation or neurological symptoms (12).…”
Section: Discussionmentioning
confidence: 99%
“…is from mouse strain III (Hpd Ϫ/Ϫ ) (13-15), a model for human hereditary tyrosinemia type 3 (27) that is characterized by elevation of blood tyrosine and the absence of visceral injuries (13,27). There is a C to T transition at nucleotide ϩ7 on exon 7 of the Hpd gene on chromosome 5 of the III mouse, the result being premature termination of translation (15).…”
Section: Phenotype Of the Double Mutants (Fahmentioning
confidence: 99%
“…Mutations in the HPD locus are related to two known distinct diseases, hereditary tyrosinemia type 3 and hawkinsinuria, and HPD activity is markedly reduced in the liver of patients with HT1 (2). HT3 is characterized by elevated blood concentrations of Tyr and massive urinary excretion of 4-hydroxyphenylpyruvic acid (4-HPP), 4-hydroxyphenyllactic acid, and hydrophenylacetic acid (3). Clinical symptoms in some patients include mild mental retardation, ataxia, and convulsions, and these symptoms are likely due to the elevation of 4-HPP and Tyr in body fluids.…”
mentioning
confidence: 99%
“…Interestingly, the deletion strain was also unable to grow on mixtures of a derepressing concentration of lactose and Phe as single carbon sources, VOL. 5, 20065, NOTE 1443 suggesting that, analogous to the situation in humans (3,18), the absence of hpdA directs the possible accumulation of 4-HPP and Tyr as toxic metabolites. Type 3 tyrosinemia is characterized by elevated blood concentrations of Tyr and massive urinary excretion of 4-HPP, 4-hydroxyphenyllactic, and 4-hydroxyphenylacetic acid (2,3,18).…”
mentioning
confidence: 99%
See 1 more Smart Citation